SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Singleton who wrote (4961)7/22/1998 11:06:00 PM
From: John Metcalf  Read Replies (1) of 6136
 
Aww, shucks, Peter. I appreciate your work, and Rick's, and Vector1's and the other Peter S (uzman). But you left out Margie, who has dug out and posted a ton of research for us.

That said.... there is an obvious lag between the discovery of value and the market's recognition of it. Market valuations can be many years behind clear signals. When Rick Harmon first mentioned Agouron (that I know about) on M.I.S., it was selling for $5.50 per share, split adjusted. By the time Alan Abelson gets it, and tells everybody else, I'll be retired -:)

As to this spin-out, what good is it to shareholders, and why does it need a prospectus, if there is not a secondary market? And, if there is a secondary market, it will sell shares sooner or later. We can all be flippers then -:)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext